Skip to main content

Table 3 Summary statistics regarding numbers of participants by funding source

From: How Can the Evidence from Global Large-scale Clinical Trials for Cardiovascular Diseases be Improved?

Parameter

Public

Private

Combined

Total

Number of trials (N)

19

289

36

344

Number of participants

    

   ≥100,000

0

2

0

2

   30,000-99,999

1

4

1

6

   10,000-29,999

1

38

3

42

   3,000-9,999

6

51

11

68

   1,000-2,999

6

88

11

105

   < 999

5

106

10

121

Mean

4,696

5,944

4,703

5,745

Standard deviation

8,877

21,485

7,299

19,934

Median

2,331

1,400

2,450

1,555

Max

39,876

300,000

40,000

300,000